Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Erratum for Aridgides et al., "<i>Pseudomonas aeruginosa lasR</i> mutants resist phagocytosis and alter inflammatory cytokine production by cystic fibrosis macrophages".

mSphere·2026
Same author

Outer membrane vesicles secreted by <i>Bacteroides fragilis</i> inhibit CFTR chloride secretion by human colon organoids.

Infection and immunity·2026
Same author

When normalization induces correlation: shared and unstable references can create hidden dependencies.

NPJ systems biology and applications·2026
Same author

<i>Pseudomonas aeruginosa lasR</i> mutants resist phagocytosis and alter inflammatory cytokine production by cystic fibrosis macrophages.

mSphere·2026
Same author

<i>Streptococcus sanguinis</i> antagonizes <i>Prevotella melaninogenica</i> in the context of the cystic fibrosis respiratory microbiome.

Journal of bacteriology·2026
Same author

Convergent strategies for nanobody-mediated inhibition of an epoxide hydrolase.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Aug 12, 2025

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms
09:51

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

Published on: May 25, 2018

34.2K

CAS12e (CASX2) CLEAVAGE OF CCR5: IMPACT OF GUIDE RNA LENGTH AND PAM SEQUENCE ON CLEAVAGE ACTIVITY.

David A Armstrong1,2,3, Taylor R Hudson1, Christine A Hodge2,3

  • 1Research Service, V.A. Medical Center, White River Junction, VT, USA, 05001.

Biorxiv : the Preprint Server for Biology
|January 30, 2023
PubMed
Summary
This summary is machine-generated.

Researchers optimized the PlmCas12e gene editing system for targeting the CCR5 gene. This advancement aids in developing therapies for HIV-1 resistance by understanding CasX2 cleavage requirements.

More Related Videos

Dissection of Enhancer Function Using Multiplex CRISPR-based Enhancer Interference in Cell Lines
10:46

Dissection of Enhancer Function Using Multiplex CRISPR-based Enhancer Interference in Cell Lines

Published on: June 2, 2018

9.4K
Substrate Generation for Endonucleases of CRISPR/Cas Systems
11:53

Substrate Generation for Endonucleases of CRISPR/Cas Systems

Published on: September 8, 2012

27.4K

Related Experiment Videos

Last Updated: Aug 12, 2025

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms
09:51

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

Published on: May 25, 2018

34.2K
Dissection of Enhancer Function Using Multiplex CRISPR-based Enhancer Interference in Cell Lines
10:46

Dissection of Enhancer Function Using Multiplex CRISPR-based Enhancer Interference in Cell Lines

Published on: June 2, 2018

9.4K
Substrate Generation for Endonucleases of CRISPR/Cas Systems
11:53

Substrate Generation for Endonucleases of CRISPR/Cas Systems

Published on: September 8, 2012

27.4K

Area of Science:

  • Molecular Biology
  • Gene Editing
  • Microbiology

Background:

  • CRISPR/Cas systems are evolving as therapeutic gene editing tools.
  • Alternative CRISPR systems, including compact Cas12e, offer diverse gene editing capabilities.
  • The CCR5 gene is a key target for HIV-1 resistance gene therapies.

Approach:

  • Investigated PlmCas12e (CasX2) endonuclease activity.
  • Optimized guide RNA lengths and protospacer adjacent motif (PAM) sequences for CCR5 gene cleavage.
  • Analyzed PlmCas12e cleavage variations based on target site, guide RNA length, and PAM sequence.

Key Points:

  • PlmCas12e exhibits a PAM preference for purines (A, G) over pyrimidines (T, C) at the fourth position of the TTCN PAM.
  • Cleavage efficiency is influenced by target site, guide RNA length, and PAM terminal nucleotide.
  • Understanding CasX2 cleavage requirements is crucial for developing CCR5-targeted gene therapies.

Conclusions:

  • Optimized PlmCas12e conditions enhance its utility for gene editing applications.
  • This research advances the development of therapies aimed at conferring HIV-1 resistance via CCR5 gene modification.
  • The findings contribute to the broader field of CRISPR-based gene therapeutics.